These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38695786)

  • 21. Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder.
    Tiger M; Farde L; Rück C; Varrone A; Forsberg A; Lindefors N; Halldin C; Lundberg J
    Psychiatry Res Neuroimaging; 2016 Jul; 253():36-42. PubMed ID: 27269199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin 1A receptor density measured by F18-Mefway PET/CT in mesiotemporal cortex and raphe does not discriminate therapeutic response in patients with major depressive episode.
    Barth M; Dunzinger A; Wimmer I; Winkler J; Rittmannsberger H; Nader M; Pichler R
    Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):203-210. PubMed ID: 29916219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A positron emission tomography study of the serotonin1B receptor effect of electroconvulsive therapy for severe major depressive episodes.
    Tiger M; Gärde M; Tateno A; Matheson GJ; Sakayori T; Nogami T; Moriya H; Varnäs K; Arakawa R; Okubo Y
    J Affect Disord; 2021 Nov; 294():645-651. PubMed ID: 34332365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder.
    Gray NA; Milak MS; DeLorenzo C; Ogden RT; Huang YY; Mann JJ; Parsey RV
    Biol Psychiatry; 2013 Jul; 74(1):26-31. PubMed ID: 23374637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.
    Spindelegger C; Lanzenberger R; Wadsak W; Mien LK; Stein P; Mitterhauser M; Moser U; Holik A; Pezawas L; Kletter K; Kasper S
    Mol Psychiatry; 2009 Nov; 14(11):1040-50. PubMed ID: 18362913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
    Knorr UB
    Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escitalopram: a review of its use in the management of major depressive disorder in adults.
    Garnock-Jones KP; McCormack PL
    CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
    Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
    CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
    Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
    Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin 1A Receptor Binding of [11C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response.
    Lan MJ; Zanderigo F; Pantazatos SP; Sublette ME; Miller J; Ogden RT; Mann JJ
    Int J Neuropsychopharmacol; 2022 Aug; 25(7):534-544. PubMed ID: 34996114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.
    Lundberg J; Tiger M; Landén M; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1167-72. PubMed ID: 22243688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders.
    Hahn A; Lanzenberger R; Wadsak W; Spindelegger C; Moser U; Mien LK; Mitterhauser M; Kasper S
    J Neurosci; 2010 Oct; 30(43):14482-9. PubMed ID: 20980606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study.
    Praschak-Rieder N; Hussey D; Wilson AA; Carella A; Lee M; Dunn E; Willeit M; Bagby RM; Houle S; Meyer JH
    Biol Psychiatry; 2004 Oct; 56(8):587-91. PubMed ID: 15476688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
    Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
    J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
    Voineskos AN; Wilson AA; Boovariwala A; Sagrati S; Houle S; Rusjan P; Sokolov S; Spencer EP; Ginovart N; Meyer JH
    Psychopharmacology (Berl); 2007 Sep; 193(4):539-45. PubMed ID: 17497139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
    Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
    J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain.
    Varnäs K; Nyberg S; Halldin C; Varrone A; Takano A; Karlsson P; Andersson J; McCarthy D; Smith M; Pierson ME; Söderström J; Farde L
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):113-23. PubMed ID: 20424633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.